It has been reported that in a cohort of sporadic prostate cancer patients treated with radical prostatectomy, the higher probability of advanced tumour stage and the reduced disease-free survival were correlated with somatic BRCA1 loss, which was due to hypermethylation or a deletion of the promoter [87]. The gene discussed is BRCA1; the disease is Familial prostate cancer.